aDepartment of Pharmaceutics, Utrecht University, P.O. Box 80082, 3508 TB Utrecht, The NetherlandsbDepartment of Innovative Cancer Diagnosis and Therapy, German Cancer Research Center, INF 280, 69120 Heidelberg, GermanycInstitute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Square 2, 16206 Prague 6, Czech Republic
Checking for direct PDF access through Ovid
Long circulating and passively tumor-targeted polymeric nanomedicines improve the interaction between i.v. applied chemotherapy and clinically relevant fractionated radiotherapy.